Zydar Pharmaceuticals Private Limited
About Zydar Pharmaceuticals Private Limited
Data last updated:
Zydar Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 04 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74999KA2018PTC111932. Its GSTIN is 23AABCZ1966C1ZJ (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Anoop Gupta Kumar (Whole-Time Director) and Sushil Awasthi (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bbmp No 190 Ground Floor 13th Cross Samsudrapalya Hsr Layout, Bangalore, Karnataka, India – 560102.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.11 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹16,362 (net margin 0.4%) and EBITDA of ₹2.01 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Company details
Contact details
Zydar Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBbmp No 190 Ground Floor 13th Cross Samsudrapalya Hsr Layout, Bangalore, Karnataka, India – 560102
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Zydar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zydar Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Zydar Pharmaceuticals Private Limited, buy the company report.
Financials of Zydar Pharmaceuticals Private Limited
FY 2025 filings availableZydar Pharmaceuticals Private Limited reported revenue of ₹37.11 Lakh (down 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16,362 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zydar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zydar Pharmaceuticals Private Limited
Zydar Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anoop Gupta Kumar | Whole-Time Director | 04 Apr 2018 | 8 Years 7 Months | Current |
| Sushil Awasthi | Whole-Time Director | 04 Apr 2018 | 8 Years 7 Months | Current |
Shareholding
The shareholding of Zydar Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Zydar Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Mar 2020 | 100366793 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Zydar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zydar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zydar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCZ1966C1ZJ | Madhya Pradesh | Active | 16 May 2018 |
To see the full GST registrations and return filing status of Zydar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zydar Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Anoop Gupta Kumar was appointed as Whole-Time Director on 04 Apr 2018.
Frequently asked questions
Zydar Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 04 April 2018 (8+ years old) and is registered under CIN U74999KA2018PTC111932.
Zydar Pharmaceuticals has 2 current directors:
- Anoop Gupta Kumar - Whole-Time Director
- Sushil Awasthi - Whole-Time Director
The latest financial statements of Zydar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Zydar Pharmaceuticals is 23AABCZ1966C1ZJ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Zydar Pharmaceuticals is U74999KA2018PTC111932. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zydar Pharmaceuticals was incorporated on 04 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Anoop Gupta Kumar was appointed as Whole-Time Director on 04 Apr 2018. Sushil Awasthi was appointed as Whole-Time Director on 04 Apr 2018.
The registered office of Zydar Pharmaceuticals is at Bbmp No 190 Ground Floor 13th Cross Samsudrapalya Hsr Layout, Bangalore, Karnataka, India – 560102.
Zydar Pharmaceuticals operates in the healthcare industry, in the medical and laboratory equipment segment.
Zydar Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
